U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
397
Substance Class Protein
Created
by admin
on Sat Jun 26 17:11:40 UTC 2021
Edited
by admin
on Sat Jun 26 17:11:40 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2A
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
PF8K38CG54
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
FREMANEZUMAB
INN  
USAN   INN  
Official Name English
FREMANEZUMAB [INN]
Common Name English
RN-307
Code English
LBR-101
Code English
IMMUNOGLOBULIN G2, ANTI-(HUMAN .ALPHA.-CALCITONIN GENE-RELATED PEPTIDE/.BETA.-CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 LIGHT CHAIN, DIMER
Systematic Name English
TEV-48125
Code English
FREMANEZUMAB [MI]
Common Name English
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CALCITONIN GENE-RELATED PEPTIDE 1 (CGRP-I))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.2 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-7*01 (86%) (IGHD)-IGHJ5*01) (8.10.13) (1-122) -HOMO SAPIENS IGHG2*01 (CH2(A
Systematic Name English
RN307
Code English
LBR101
Code English
TEV48125
Code English
PF-04472429
Code English
FREMANEZUMAB [USAN]
Common Name English
PF04472429
Code English
FREMANEZUMAB [WHO-DD]
Common Name English
Code System Code Type Description
CAS
1655501-53-3
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
NCI_THESAURUS
C174842
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
INN
10299
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
DRUG BANK
DB14041
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
DRUG CENTRAL
5315
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
RXCUI
2056691
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
FDA UNII
PF8K38CG54
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
RXCUI
2056690
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
ALTERNATIVE
MERCK INDEX
M12104
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
LACTMED
Fremanezumab
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
From To
1_22 1_98
1_136 3_214
1_149 1_205
1_224 2_224
1_225 2_225
1_228 2_228
1_231 2_231
1_262 1_322
1_368 1_426
2_22 2_98
2_136 4_214
2_149 2_205
2_262 2_322
2_368 2_426
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
CALCITONIN GENE-RELATED PEPTIDE
TARGET -> INHIBITOR
BINDING
FREMANEZUMAB-VFRM
INNOVATOR->PARENT
FREMANEZUMAB-VFRM
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
FREMANEZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966